2018-11-05T14:13:01-06:00 2018-06-30 953001179 WINDES INC PO BOX 87 LONG BEACH CA 908010087 990 2017-07-01 330841281 PANCREATIC CANCER ACTION NETWORK INC PANC 3107250025 1500 ROSECRANS AVENUE NO 200 MANHATTAN BEACH CA 90266 ABIGAIL WINSTON CFO/COO 3107250025 2018-10-30 1 DONITA M JOSEPH P00286656 5624351191 2018-10-30 66.215.11.242 2018-10-30 11:38:46 PD P 775A2711D1EE3D5BA0ABE46AED326317FF9873BE FAA4A87504889BA9051C5890A3D1561A7470D032 2017 2019-02-21 02:37:17Z JULIE FLESHMAN 1500 ROSECRANS AVENUE NO 200 MANHATTAN BEACH CA 90266 82222056 0 X WWW.PANCAN.ORG X 1999 CA TO ADVANCE RESEARCH, SUPPORT PATIENTS, AND CREATE HOPE FOR PEOPLE WHO HAVE PANCREATIC CANCER. 14 13 185 2620 0 54846 35758286 53040826 6515 4100 247956 661178 -1823166 -1762547 34189591 51943557 4892840 4076081 0 0 13510714 13377470 130790 0 3013274 13574525 15396151 32108869 32849702 2080722 19093855 37598772 56135611 13755602 13300815 23843170 42834796 X THE PANCREATIC CANCER ACTION NETWORK (PANCAN) IS DEDICATED TO FIGHTING THE WORLD'S TOUGHEST CANCER. IN OUR URGENT MISSION TO SAVE LIVES, WE ATTACK PANCREATIC CANCER ON ALL FRONTS: RESEARCH, CLINICAL INITIATIVES, PATIENT SERVICES AND ADVOCACY. OUR EFFORT IS AMPLIFIED BY A NATIONWIDE NETWORK OF GRASSROOTS SUPPORT. WE ARE DETERMINED TO IMPROVE PATIENT OUTCOMES TODAY AND DOUBLE SURVIVAL BY 2020. 0 0 14112356 4200000 RESEARCH GRANTS AND CLINICAL INITIATIVES - PANCAN'S RESEARCH GRANTS AND CLINICAL INITIATIVES ARE CHANGING THE LANDSCAPE OF PANCREATIC CANCER RESEARCH. THE RESEARCH GRANTS DEPARTMENT ADMINISTERS A COMPETITIVE GRANTS PROGRAM, AWARDING THE MOST MERITORIOUS RESEARCH PROJECTS WITH A FOCUS ON THOSE THAT ADVANCE OUR CLINICAL INITIATIVES, TO THE BRIGHTEST SCIENTISTS, TO TRANSLATE THE BEST RESEARCH INTO THE CLINIC. TO DATE THE GRANTS PROGRAM HAS FUNDED 168 GRANTS, TOTALING NEARLY $44.5M IN FUNDING, WHICH WAS DISTRIBUTED TO 167 SCIENTISTS AT 62 INSTITUTIONS AROUND THE COUNTRY. GROUNDBREAKING INITIATIVES LIKE OUR "KNOW YOUR TUMOR" PRECISION MEDICINE SERVICE, AND PRECISION PROMISE, AN INNOVATIVE CLINICAL TRIAL PLATFORM FOR PATIENTS WITH PANCREATIC CANCER, PLAY A PIVOTAL ROLE IN CHANGING OUTCOMES FOR PATIENTS. 1797696 4100 GOVERNMENT AFFAIRS AND ADVOCACY - WE DRIVE LEGISLATIVE SUPPORT FOR INCREASED FEDERAL RESEARCH FUNDING - CRITICAL BECAUSE APPROXIMATELY 80 PERCENT OF ALL PANCREATIC CANCER RESEARCH FUNDING COMES FROM THE FEDERAL GOVERNMENT. WE LED THE TIRELESS FIGHT TO SUCCESSFULLY PASS THE RECALCITRANT CANCER RESEARCH ACT IN CONGRESS, MAKING PANCREATIC CANCER A NATIONAL PRIORITY, AND THE 21ST CENTURY CURES ACT, WHICH MAKES IT POSSIBLE FOR CONGRESS TO DIRECT MORE FUNDING TO CANCER RESEARCH. ALONG WITH OUR SUPPORTERS, WE HAVE CREATED A GRASSROOTS MOVEMENT - TELLING OUR STORIES TO CONGRESS IN AN EFFORT TO RAISE MORE AWARENESS ABOUT PANCREATIC CANCER, AND IN TURN, THE CRITICAL NEED FOR MORE RESEARCH FUNDING. AS OF 2016, NCI FUNDING FOR PANCREATIC CANCER RESEARCH HAD INCREASED TO MORE THAN $152 MILLION. 3078885 PATIENT SERVICES (PATIENT CENTRAL) - PATIENT CENTRAL IS A COMPREHENSIVE SERVICE PROVIDING IMMEDIATE AND FREE INFORMATION AND EDUCATION ABOUT PANCREATIC CANCER, DIAGNOSIS, TREATMENT OPTIONS, CLINICAL TRIALS, DIET AND NUTRITION, SPECIALISTS AND SUPPORT RESOURCES TO HELP THEM MAKE INFORMED DECISIONS WITH THEIR HEALTHCARE TEAM. WE HAVE THE LARGEST, MOST UP-TO-DATE CLINICAL TRIALS DATABASE IN THE COUNTRY AND PROVIDE PATIENTS WITH PERSONALIZED CLINICAL TRIAL SEARCHES SO THAT THEY UNDERSTAND ALL OF THEIR TREATMENT OPTIONS. OUR PATIENT CENTRAL STAFF - MADE UP OF EXPERT, UNDERSTANDING, COMPASSIONATE PEOPLE - SHARES MORE RESOURCES AND SPEAKS WITH MORE PANCREATIC CANCER PATIENTS THAN ANY OTHER CANCER ORGANIZATION IN THE WORLD. OUR PATIENT REGISTRY, AN ACTIVE DATABASE OF PATIENT INFORMATION, WAS DEVELOPED TO HELP ADVANCE RESEARCH AND IMPROVE CARE FOR PATIENTS BATTLING PANCREATIC CANCER. 6521672 55166 COMMUNITY ENGAGEMENT - WITH 60 AFFILIATES AND A VOLUNTEER CORPS OF MORE THAN 8,000 PEOPLE, WE RAISE FUNDS AND NATIONAL AWARENESS OF THE DISEASE THROUGH OUR PURPLESTRIDE RUN/WALK EVENTS IN COMMUNITIES NATIONWIDE. OVER 84,000 PARTICIPANTS HAVE ATTENDED OUR SIGNATURE EVENTS THIS PAST YEAR. OUR GRASSROOTS EFFORTS HARNESS THE PASSION, POWER AND ENERGY OF DEDICATED VOLUNTEERS - MANY OF WHOM HAVE LOST LOVED ONES TO THE DISEASE AND ARE COMMITTED TO FIGHTING BACK. OUR GRASSROOTS EFFORTS HAVE ALSO RESULTED IN A GLOBAL MOVEMENT - WE PLAY A LEAD ROLE IN THE WORLD PANCREATIC CANCER COALITION, COMPOSED OF MORE THAN 76 PANCREATIC CANCER PATIENT GROUPS FROM 34 COUNTRIES ON 6 CONTINENTS. WE ALSO SPEARHEADED THE FIRST WORLD PANCREATIC CANCER DAY, NOW OBSERVED EACH NOVEMBER DURING PANCREATIC CANCER AWARENESS MONTH. 6521672 55166 25510609 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 1 1 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 144 0 1 185 1 1 1 0 0 0 0 1 1 0 0 0 0 0 X 14 13 0 0 0 0 0 0 0 1 1 0 1 1 1 1 1 1 1 1 1 1 0 AL AK AZ AR CA CO CT DE DC FL GA ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY HI X X ABIGAIL WINSTON CFOCOO 3107250025 1500 ROSECRANS AVENUE STE 200 MANHATTAN BEACH CA 90266 JULIE FLESHMAN PRES. & CEO/DIR./EX-OFFICIO 50.00 X X 458058 0 19628 JEANNE WEAVER RUESCH CHAIRMAN 2.00 X X 0 0 0 HILARIE KOPLOW-MC ADAMS VICE CHAIRMAN 2.00 X X 0 0 0 STUART RICKERSON SECRETARY 2.00 X X 0 0 0 LAURIE MACCASKILL BOARD MEMBER/PAST CHAIR 2.00 X 0 0 0 PETER KOVLER BOARD MEMBER 2.00 X 0 0 0 TERRENCE MECK BOARD MEMBER 2.00 X 0 0 0 MICHAEL KORENGOLD BOARD MEMBER 2.00 X 0 0 0 JASON KUHN BOARD MEMBER 2.00 X 0 0 0 CRAIG A ROGERSON BOARD MEMBER 2.00 X 0 0 0 PETER CASHION BOARD MEMBER 2.00 X 0 0 0 SCOTT A GRISWOLD BOARD MEMBER 2.00 X 0 0 0 BARBARA J KENNER BOARD MEMBER 2.00 X 0 0 0 KAREN YOUNG BOARD MEMBER 2.00 X 0 0 0 LYNN MATRISIAN CHIEF SCIENCE OFFICER 50.00 X 294065 0 22222 ABIGAIL WINSTON CFO/COO 50.00 X 208044 0 17847 MARK EDMIASTON CHIEF DEV. & COMM. ENGMNT OFFICER 50.00 X 246867 0 14287 JENNY ISAACSON VP, STRATEGIC PARTNERSHIPS 50.00 X 200518 0 15765 VICTORIA MANAX CHIEF MEDICAL OFFICER 50.00 X 475669 0 18492 TAKESHI FUJII VP, INFORMATION TECH 50.00 X 193644 0 12090 RICHARD LEONARD CHIEF GIFT OFFICER 50.00 X 255163 0 21102 MICHAEL ROSEN CHIEF COMMUNICATIONS OFFICER 50.00 X 217320 0 15741 2549348 0 157174 27 0 1 0 AACR 615 CHESTNUT STREET 17TH FLOOR PHILADELPHIA PA 191064404 GRANT PEER REVIEW & ADMIN 3364300 PERSONALIZED CANCER THERAPY 1616 ANDERSON ROAD MCLEAN VA 22102 CLINICAL RESEARCH 1516750 SPRINGBOX 708 CONGRESS AVENUE AUSTIN TX 78701 PATIENT SERVICES 764255 BLACKBAUD INC PO BOX 930256 ATLANTA GA 311930256 SOFTWARE MAINTENANCE & SUBSCRIPTIONS 650829 BERRY CONSULTANTS LLC 3345 BEE CAVES ROAD SUITE 201 AUSTIN TX 78746 PRECISION PROMISE 521332 28 223836 15268858 37548132 380647 53040826 GOV'T AFFAIRS AND ADVOCACY 900099 4100 4100 4100 553922 553922 28277169 28169913 107256 107256 107256 209925 15268858 2042492 -1832567 -1832567 121260 66094 55166 55166 OTHER INCOME 900099 14854 14854 14854 51943557 59266 0 -1156535 X 3576081 3576081 500000 500000 1247712 798851 314365 134496 10315319 7433595 1546659 1335065 322223 233083 48415 40725 674841 499262 99040 76539 817375 555393 165145 96837 316587 316587 31575 31575 16895 16895 116297 116297 5993275 5703742 112254 177279 1094456 941954 26764 125738 914329 439890 57482 416957 596227 442990 77903 75334 1262067 902741 200763 158563 593223 521850 6550 64823 1758583 1691233 64104 3246 786642 712054 41108 33480 162326 162326 BANK & PROCESSING FEES 919304 801829 117475 ALL OTHER EXPENSES 420151 313968 50678 55505 MISCELLANEOUS & SPECIAL 218789 31602 85975 101212 GRANTEE DEVELOPMENT 195425 195425 32849702 25510609 4325819 3013274 997119 1470601 2221261 4409417 14828340 23987986 589330 471546 47537 33984 430375 477296 5127684 2955913 2508204 2171771 15819701 22948400 156905 164610 37598772 56135611 2757863 2971172 10426389 9826906 571350 502737 13755602 13300815 X 13932927 16241678 9910243 26593118 23843170 42834796 37598772 56135611 19093855 -102229 0 X 0 1 X 1 0 X 23340614 38414247 34319563 35758286 53040826 184873536 23340614 38414247 34319563 35758286 53040826 184873536 47110891 137762645 376936 404154 453860 423003 553922 2211875 -4610 14854 10244 187095655 389133 0.73630 0.81880 X 6870 10025 16895 28548096 28564991 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 310716 235587 249503 16895 812701 250000 250000 250000 250000 1000000 1500000 56293 49094 47215 6870 159472 SCHEDULE C, PART II-A OFFICE IN WASHINGTON DC ENGAGES IN DEVELOPING REPORT LANGUAGE FOR APPROPRIATIONS BILLS; DEVELOPING ALERTS TO OUR MEMBERS REGARDING SPECIFIC LEGISLATION; PREPARING FOR AND ATTENDING VISITS ON CAPITAL HILL BY OUR MEMBERS AND THE PUBLIC DURING ADVOCACY DAYS; GIVING UNINVITED AND INVITED TESTIMONY OR WRITTEN RESPONSES DURING LEGISLATIVE HEARINGS; DEVELOPING GENERAL EDUCATION MESSAGES THROUGH MEDIA CAMPAIGNS THAT DO OR DO NOT INCLUDE A CALL FOR ACTION. 836255 423482 412773 495600 402446 93154 3795829 2129985 1665844 2171771 CAPITAL LEASE OBLIGATIONS 10391 DEFERRED LEASE LIABILITY 450949 FINANCING OBLIGATIONS 41397 502737 X 51725031 -102229 -102229 51827260 116297 116297 51943557 32733405 0 32733405 116297 116297 32849702 PART X, LINE 2: THE ORGANIZATION RECOGNIZES THE FINANCIAL STATEMENT BENEFIT OF TAX POSITIONS, SUCH AS FILING STATUS OF TAX-EXEMPT, ONLY AFTER DETERMINING THAT THE RELEVANT TAX AUTHORITY WOULD MORE LIKELY THAN NOT SUSTAIN THE POSITION FOLLOWING AN AUDIT. THE ORGANIZATION IS SUBJECT TO POTENTIAL INCOME TAX AUDITS ON OPEN TAX YEARS BY ANY TAXING JURISDICTION IN WHICH IT OPERATES. THE STATUTE OF LIMITATIONS FOR FEDERAL AND CALIFORNIA STATE PURPOSES IS GENERALLY THREE AND FOUR YEARS, RESPECTIVELY. 1 NORTH AMERICA 0 0 GRANT TO RECIPIENT LOCATED IN REGION GRANTMAKING 500000 0 0 0 0 0 0 500000 0 500000 NORTH AMERICA FUND CANCER RESEARCH 500000 CHECK 0 FMV 0 0 0 0 0 0 PART I, LINE 2: THE PANCREATIC CANCER ACTION NETWORK ADMINISTERS ITS GRANTS PROGRAM, IN HOUSE. THE AMOUNT OF THE GRANTS AND ELIGBILITY CRITERIA ARE DETERMINED BY THE ORGANIZATION'S SCIENTIFIC ADVISORY BOARD IN ADVANCE OF PUBLIC NOTIFICATION OF GRANT AVAILABILITY. GRANTS ARE SELECTED BY SCIENTIFIC REVIEW PERFORMED BY A PANEL OF PEER EXPERTS. ALL GRANT AMOUNTS, ELIGIBILITY CRITERIA, AND REVIEW PROCESSES ARE DOCUMENTED ANNUALLY IN THE INDIVIDUAL GRANT APPLICATION PROCEDURE DOCUMENTS. GRANT AMOUNTS AND REVIEW PROCESSES ARE SPECIFIED IN THE GRANT AGREEMENT BETWEEN THE GRANTEE'S INSTITUTION AND THE ORGANIZATION. PROGRESS REPORTS ARE REQUIRED FOR ALL GRANTS AWARDED - TWICE YEARLY. THESE PROGRESS REPORTS ARE COLLECTED BY THE GRANTS ASSOCIATE DIRECTOR AND DOCUMENTED IN THE INDIVIDUAL GRANT POST AWARD FILES. PROGRESS REPORTS INCLUDE A DESCRIPTION OF THE RESEARCH WORK ACCOMPLISHED, FUNDS USED, LESSONS LEARNED AND OTHER OUTCOMES. FINAL REPORTS ARE DUE WITHIN TWO MONTHS OF THE COMPLETION OF THE GRANT PERIOD AND MUST ACCOUNT FOR THE ENTIRE GRANT AMOUNT. THE PANCREATIC CANCER ACTION NETWORK PROGRAM ASSOCIATE DIRECTOR REVIEWS ALL PROGRESS AND FINAL REPORTS. ANNUAL REPORTS ARE ALSO EVALUATED BY MEMBERS OF THE SCIENTIFIC ADVISORY COMMITTEE THAT DETERMINED FUNDING DECISIONS. PROGRAM ASSOCIATE DIRECTOR COMMUNICATES DIRECTLY WITH GRANT RECIPIENTS TO RESOLVE QUESTIONS OR DISCREPANCIES. THIS PROCESS IS DOCUMENTED IN THE GRANT AGREEMENT BETWEEN THE GRANTEE INSTITUTION AND THE ORGANIZATION. WALKS AND RUNS 14840283 14840283 1832567 GALA 638500 428575 209925 135324 74601 15478783 15268858 209925 135324 74601 1832567 2042492 -1832567 SCHEDULE G, PART I, LINE 3 THE ORGANIZATION IS REGISTERED TO FUNDRAISE IN EVERY STATE. IN FISCAL YEAR 2018, THE PROPER STATE REGISTRATION FORMS WERE FILED. 1 DANA-FARBER CANCER INSTITUTE 450 BROOKLINE AVENUE BOSTON MA 02215 042263040 501(C)(3) 500000 FUND RESEARCH COLUMBIA UNIVERSITY 154 HAVEN AVENUE 2ND FLOOR NEW YORK NY 10032 135598093 501(C)(3) 500000 FUND RESEARCH H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE 12902 MAGNOLIA DRIVE TAMPA FL 33612 592451713 501(C)(3) 200000 FUND RESEARCH RUTGERS THE STATE UNIVERSITY OF NEW JERSEY 33 KNIGHTSBRIDGE ROAD PISCATAWAY NJ 08854 462354111 501(C)(3) 500000 FUND RESEARCH NEW YORK UNIVERSITY SCHOOL OF MEDICINE ONE PARK AVENUE 6TH FLOOR NEW YORK NY 10016 135562308 501(C)(3) 500000 FUND RESEARCH THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE BOULEVARD HOUSTON TX 77030 746001118 501(C)(3) 500000 FUND RESEARCH MEMORIAL SLOAN-KETTERING CANCER CENTER 1275 YORK AVENUE NEW YORK NY 10065 131624182 501(C)(3) 500000 FUND RESEARCH STATE UNIVERSITY OF NEW YORK STONY BROOK UNIVERSITY W5510 MELVILLE LIBRARY STONY BROOK NY 11794 141368361 501(C)(3) 500000 FUND RESEARCH FUND RESEARCH FUND RESEARCH 8 PART I, LINE 2: THE PANCREATIC CANCER ACTION NETWORK ADMINISTERS ITS GRANTS PROGRAM, IN HOUSE. THE AMOUNT OF THE GRANTS AND ELIGBILITY CRITERIA ARE DETERMINED BY THE ORGANIZATION'S SCIENTIFIC ADVISORY BOARD IN ADVANCE OF PUBLIC NOTIFICATION OF GRANT AVAILABILITY. GRANTS ARE SELECTED BY SCIENTIFIC REVIEW PERFORMED BY A PANEL OF PEER EXPERTS. ALL GRANT AMOUNTS, ELIGIBILITY CRITERIA, AND REVIEW PROCESSES ARE DOCUMENTED ANNUALLY IN THE INDIVIDUAL GRANT APPLICATION PROCEDURE DOCUMENTS. GRANT AMOUNTS AND REVIEW PROCESSES ARE SPECIFIED IN THE GRANT AGREEMENT BETWEEN THE GRANTEE'S INSTITUTION AND THE ORGANIZATION. PROGRESS REPORTS ARE REQUIRED FOR ALL GRANTS AWARDED - TWICE YEARLY. THESE PROGRESS REPORTS ARE COLLECTED BY THE GRANTS ASSOCIATE DIRECTOR AND DOCUMENTED IN THE INDIVIDUAL GRANT POST AWARD FILES. PROGRESS REPORTS INCLUDE A DESCRIPTION OF THE RESEARCH WORK ACCOMPLISHED, FUNDS USED, LESSONS LEARNED AND OTHER OUTCOMES. FINAL REPORTS ARE DUE WITHIN TWO MONTHS OF THE COMPLETION OF THE GRANT PERIOD AND MUST ACCOUNT FOR THE ENTIRE GRANT AMOUNT. THE PANCREATIC CANCER ACTION NETWORK PROGRAM ASSOCIATE DIRECTOR REVIEWS ALL PROGRESS AND FINAL REPORTS. ANNUAL REPORTS ARE ALSO EVALUATED BY MEMBERS OF THE SCIENTIFIC ADVISORY COMMITTEE THAT DETERMINED FUNDING DECISIONS. PROGRAM ASSOCIATE DIRECTOR COMMUNICATES DIRECTLY WITH GRANT RECIPIENTS TO RESOLVE QUESTIONS OR DISCREPANCIES. THIS PROCESS IS DOCUMENTED IN THE GRANT AGREEMENT BETWEEN THE GRANTEE INSTITUTION AND THE ORGANIZATION. SCHEDULE I, PART II GRANTS REPORTED ON SCHEDULE I, PART II ARE GREATER THAN GRANTS REPORTED ON FORM 990, PART IX, LINE 1 DUE TO PRIOR YEAR GRANT REFUNDS. FORM 990, PART IX, LINE 1 IS A NET AMOUNT OF CURRENT YEAR GRANTS AND PRIOR YEAR GRANT REFUNDS. SCHEDULE I, PART II TOTAL GRANTS 3,700,000 PRIOR YEAR GRANT REFUNDS (123,919) ------------- FORM 990, PART IX, LINE 1 GRANTS 3,576,081 X X X X X X 1 1 0 0 0 0 0 0 0 JULIE FLESHMAN PRES. & CEO/DIR./EX-OFFICIO 322056 0 130002 0 6000 0 13574 0 6054 0 477686 0 0 0 LYNN MATRISIAN CHIEF SCIENCE OFFICER 262048 0 32017 0 0 0 10672 0 11550 0 316287 0 0 0 ABIGAIL WINSTON CFO/COO 186357 0 21687 0 0 0 7615 0 10232 0 225891 0 0 0 MARK EDMIASTON CHIEF DEV. & COMM. ENGMNT OFFICER 234175 0 12692 0 0 0 8183 0 6104 0 261154 0 0 0 JENNY ISAACSON VP, STRATEGIC PARTNERSHIPS 175630 0 24888 0 0 0 7708 0 8057 0 216283 0 0 0 VICTORIA MANAX CHIEF MEDICAL OFFICER 295138 0 180531 0 0 0 12600 0 5892 0 494161 0 0 0 TAKESHI FUJII VP, INFORMATION TECH 132178 0 19669 0 41797 0 5300 0 6790 0 205734 0 0 0 RICHARD LEONARD CHIEF GIFT OFFICER 224923 0 30240 0 0 0 9580 0 11522 0 276265 0 0 0 MICHAEL ROSEN CHIEF COMMUNICATIONS OFFICER 206935 0 10385 0 0 0 7500 0 8241 0 233061 0 0 0 PART I, LINES 4A-B THE FOLLOWING INDIVIDUALS RECEIVED A SEVERANCE PAYMENT AS FOLLOWS: TAKESHI FUJII $ 41,797 X 264 FMV X 32 364920 FMV X 2 650 FMV X 10 11662 FMV X TANGIBLE GOODS, GIFT CARDS 11 3031 FMV X MISC. GOODS 2 120 FMV 0 1 0 PART I, COLUMN (B): THE NUMBER IN COLUMN (B) REPRESENTS THE NUMBER OF CONTRIBUTIONS. FORM 990, PART VI, SECTION B, LINE 11B THE AUDIT AND INVESTMENT COMMITTEE ("AIC") RECEIVES AND REVIEWS THE DRAFT OF THE FORM 990, INCLUDING SCHEDULES, PRIOR TO THE FILING OF THE RETURN. A MEETING OF THE AIC, INCLUDING THE PRESIDENT AND CEO, THE CFO, THE CONTROLLER, AND THE OUTSIDE CPA FIRM, IS THEN HELD TO REVIEW AND REVISE AS NECESSARY THE DRAFT OF THE FORM 990. UPON APPROVAL OF THE DRAFT FORM 990 BY THE AIC, THE FINAL FORM 990, WITH CHANGES REFLECTED, IF ANY, IS E-MAILED TO THE ENTIRE BOARD OF DIRECTORS PRIOR TO FILING FOR ITS REVIEW. UPON ITS APPROVAL, THE FINAL FORM 990 IS FILED ELECTRONICALLY. FORM 990, PART VI, SECTION B, LINE 12C THE BOARD OF DIRECTORS IS REQUIRED TO SUBMIT AN UPDATED CONFLICT OF INTEREST STATEMENT ON AN ANNUAL BASIS. TO THE EXTENT THAT RELATIONSHIPS ARE IDENTIFIED VIA THESE STATEMENTS AND OTHER INFORMATION, THE INDIVIDUAL'S CONSTITUENT RECORD IN THE COMPANY DATA BASE IS UPDATED TO INCLUDE THIS INFORMATION, FACILITATING PERIODIC QUERIES, AS NECESSARY. THE MEMBER WITH A CONFLICT MUST IDENTIFY THE CONFLICT AT ANY BOARD MEETING WHERE THE CONFLICT IS RELEVENT. THE MEMBER CANNOT BE PRESENT AT ANY PART OF THE MEETING WHERE THE RELEVENT TOPIC IS DISCUSSED OR VOTED ON. THE MEMBER CANNOT BE COUNTED FOR A QUORUM. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD COMPENSATION COMMITTEE IS RESPONSIBLE FOR THE REVIEW AND APPROVAL OF TOP-LEVEL EXECUTIVE MANAGEMENT COMPENSATION ANNUALLY. THE VP OF HUMAN RESOURCES STAYS ABREAST OF INDUSTRY SALARY LEVELS AND ALERTS THE COMMITTEE TO ANY CHANGE IN SALARY LEVELS. INDEPENDENT PROFESSIONAL EXPERTS ARE CALLED UPON FOR HIGHER-LEVEL POSITIONS AND ASSIST IN ESTABLISHING EXECUTIVE SALARIES IN THE COMPETITIVE MARKETPLACE. SALARIES IN BOTH FOR PROFIT AND NOT FOR PROFIT ORGANIZATIONS ARE EVALUATED IN ORDER TO ATTRACT THE MOST TALENTED PERSONNEL. INFORMATION IS GATHERED, ANALYZED AND REPORTED TO THE COMMITTEE PRIOR TO THEIR MEETINGS ON COMPENSATION WITH THE INTENT OF ENSURING THAT THE EXECUTIVE COMPENSATION PROGRAM FALLS WITHIN A REASONABLE RANGE OF COMPETITIVE PRACTICES FOR COMPARABLE POSITIONS AMONG SIMILARLY SITUATED ORGANIZATIONS. THE REVIEW INCLUDES INCENTIVE PLANS AND ALL FRINGE BENEFITS AS WELL AS BASE SALARY ARRANGEMENTS. THE BOARD ESTABLISHES THE CEO/PRESIDENT SALARY LEVEL DURING THE EXECUTIVE SESSION OF A CALLED BOARD MEETING. ONCE APPROVED, EXECUTIVE COMPENSATION PACKAGES ARE FORMALIZED IN WRITING AND ONCE ACCEPTED BY THE EXECUTIVE, RETAINED IN THE EXECUTIVES' PERSONNEL FILE(S). FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION HAS A FORMAL POLICY FOR PUBLIC DISCLOSURE AND INSPECTION OF DOCUMENTS. THE POLICY IS POSTED ON THE ORGANIZATION'S WEB-SITE. FORM 990, PART IX, LINE 11G CLINICAL RESEARCH: PROGRAM SERVICE EXPENSES 4,306,254. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 4,306,254. PROFESSIONAL FEES - RECRUITMENT AND HR: PROGRAM SERVICE EXPENSES 199,214. MANAGEMENT AND GENERAL EXPENSES 43,691. FUNDRAISING EXPENSES 34,833. TOTAL EXPENSES 277,738. PROFESSIONAL FEES - GRAPHIC AND WEB DESIGN: PROGRAM SERVICE EXPENSES 148,702. MANAGEMENT AND GENERAL EXPENSES 25,287. FUNDRAISING EXPENSES 41,720. TOTAL EXPENSES 215,709. PROFESSIONAL FEES - TECHNOLOGY: PROGRAM SERVICE EXPENSES 160,449. MANAGEMENT AND GENERAL EXPENSES 17,747. FUNDRAISING EXPENSES 29,999. TOTAL EXPENSES 208,195. PROFESSIONAL FEES - PAYROLL AND ADMINISTRATION: PROGRAM SERVICE EXPENSES 28,720. MANAGEMENT AND GENERAL EXPENSES 6,364. FUNDRAISING EXPENSES 5,312. TOTAL EXPENSES 40,396. PROFESSIONAL FEES - MEDIA PRODUCTION: PROGRAM SERVICE EXPENSES 36,066. MANAGEMENT AND GENERAL EXPENSES 295. FUNDRAISING EXPENSES 239. TOTAL EXPENSES 36,600. PROFESSIONAL FEES - OTHER: PROGRAM SERVICE EXPENSES 824,337. MANAGEMENT AND GENERAL EXPENSES 18,870. FUNDRAISING EXPENSES 65,176. TOTAL EXPENSES 908,383. FORM 990 PART VI, LINE 10B COMPANY "AFFILIATES" CONSIST OF VOLUNTEERS WHO AGREE TO PERFORM THEIR VOLUNTEER ACTIVITIES IN COMPLIANCE WITH GUIDELINES PROVIDED IN A COMMUNITY OUTREACH AFFILIATE AGREEMENT. THERE ARE NO NON-VOLUNTEER AFFILIATES, CHAPTERS OR BRANCHES (E.G., NO LEGAL ENTITIES). FORM 990, PART VIII, LINE 8C THE PANCREATIC CANCER ACTION NETWORK AND THEIR NETWORK OF VOLUNTEER AFFILIATES HELD WALKS, RUNS, AND BIKE EVENTS ALL OVER THE NATION TO BOTH FUNDRAISE AND RAISE PUBLIC AWARENESS ABOUT PANCREATIC CANCER. ALL REVENUE RAISED FROM THE EVENTS ARE CONSIDERED TO BE CHARITABLE CONTRIBUTIONS. THE ENTITY DOES INCUR EXPENSES IN CONDUCTING THE EVENTS, BUT BECAUSE ALL INCOME IS CATEGORIZED AS CONTRIBUTION REVENUE, IT IS REPORTED AS A LOSS FROM SPECIAL EVENTS, EVEN THOUGH THE EVENT WAS PROFITABLE.